Cartalax 20 mg

Cartalax is a short synthetic bioregulatory peptide studied for its role in cartilage-related cellular regulation and joint tissue research models. Scientific interest in Cartalax focuses on how small peptides may influence chondrocyte activity, extracellular matrix organization, and cellular signaling pathways associated with cartilage maintenance and degeneration.

Rather than acting as a direct pharmacological agent, Cartalax is investigated for its regulatory influence on gene expression, protein synthesis, and adaptive cellular responses within connective tissue environments. These properties make it relevant to experimental studies involving joint health, cartilage integrity, and age-related tissue changes.

(Khavinson et al., 2009 — Advances in Gerontology).

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.